Table 5.
Unadjusted Estimate (95% CI) | Adjusted Estimate (95% CI) | |
---|---|---|
GP visits (non-IBD) | 1.28 (1.02–1.61) | 1.04 (0.83–1.31) |
GP visits (IBD) | 0.70 (0.45–1.11) | 0.51 (0.35–0.74) |
SP visits (non-IBD) | 1.19 (0.81–1.76) | 0.97 (0.71–1.34) |
SP visits (IBD) | 0.91 (0.56–1.46) | 0.77 (0.55–1.10) |
Hospitalization (non-IBD) | 1.47a (0.96–2.25) | 1.20a (0.75–1.92) |
Hospitalization (IBD) | 0.86a (0.61–1.22) | 0.70a (0.46–1.05) |
Hospital days (non-IBD) | 1.36 (0.63–2.91) | 1.01 (0.35–2.94) |
Hospital days (IBD) | 0.68 (0.27–1.71) | 0.48 (0.24–0.97) |
IBD drugs | 0.79 (0.62–1.02) | 0.81 (0.61–1.06) |
Psychotropic drugs | 1.05 (0.59–1.89) | 0.82 (0.40–1.72) |
Antibiotic drugs | 1.20 (0.87–1.67) | 0.96 (0.70–1.33) |
Other drugs | 1.30 (0.88–1.93) | 0.89 (0.65–1.22) |
a Indicate Odds Ratio; Bold estimates are statistically significant at α = 0.05